[Ethonium in the treatment of patients with gastric and duodenal peptic ulcers].
Overall thirty-six patients with gastric and duodenal ulcer were evaluated for the clinical effectiveness of ethonium. The results obtained showed sufficient effectiveness of this drug preparation in the therapy of the above medical conditions. The mild course of ulcer disease appears to be treatable by monotherapy, while moderately severe and severe courses require incorporation of other medicinal agents into therapeutic plans, specifically, those from the group of blockers H2-histaminic receptors. Ethonium is well tolerated by patients, side effects are rare and do not require special treatment, which facts allow it to be included into strategies for treating peptic ulcer.
Babak
O Ia
OIa
Kushnir
I E
IE
D000208:Acute Disease; D000328:Adult; D000897:Anti-Ulcer Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy; D016480:Helicobacter pylori; D006801:Humans; D008297:Male; D000644:Quaternary Ammonium Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D013276:Stomach Ulcer / Q000175:diagnosis / Q000188:drug therapy*
D000897:Anti-Ulcer Agents; D000644:Quaternary Ammonium Compounds; C004921:Ethonium